Leede Financial Issues Optimistic Estimate for QIPT Earnings

Quipt Home Medical Corp. (NASDAQ:QIPT - Free Report) - Research analysts at Leede Financial raised their FY2025 earnings estimates for shares of Quipt Home Medical in a note issued to investors on Monday, July 7th. Leede Financial analyst D. Loe now expects that the company will post earnings per share of ($0.33) for the year, up from their prior estimate of ($0.35). The consensus estimate for Quipt Home Medical's current full-year earnings is ($0.05) per share. Leede Financial also issued estimates for Quipt Home Medical's FY2026 earnings at ($0.37) EPS and FY2027 earnings at ($0.33) EPS.

Quipt Home Medical (NASDAQ:QIPT - Get Free Report) last issued its quarterly earnings results on Monday, May 12th. The company reported ($0.07) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.02 by ($0.09). The business had revenue of $57.40 million for the quarter, compared to the consensus estimate of $88.29 million. Quipt Home Medical had a negative return on equity of 8.38% and a negative net margin of 3.66%.

A number of other equities analysts have also commented on the stock. Benchmark reaffirmed a "buy" rating and set a $4.00 target price (down from $6.00) on shares of Quipt Home Medical in a research report on Wednesday, May 14th. Wall Street Zen downgraded shares of Quipt Home Medical from a "hold" rating to a "sell" rating in a research note on Thursday, May 22nd. Finally, Canaccord Genuity Group reiterated a "hold" rating and set a $1.70 price objective (down from $4.00) on shares of Quipt Home Medical in a research note on Tuesday, May 13th.

Quipt Home Medical Trading Up 0.3%

Shares of NASDAQ:QIPT traded up $0.01 during trading on Wednesday, reaching $1.89. 82,834 shares of the company were exchanged, compared to its average volume of 401,094. The firm has a market capitalization of $81.88 million, a PE ratio of -8.98 and a beta of 0.56. The business's fifty day simple moving average is $1.89 and its 200-day simple moving average is $2.34. Quipt Home Medical has a 12-month low of $1.35 and a 12-month high of $4.07. The company has a debt-to-equity ratio of 0.76, a current ratio of 1.22 and a quick ratio of 0.85.

Institutional Investors Weigh In On Quipt Home Medical

Institutional investors have recently bought and sold shares of the company. ProShare Advisors LLC acquired a new stake in Quipt Home Medical in the fourth quarter valued at approximately $36,000. Wells Fargo & Company MN lifted its stake in shares of Quipt Home Medical by 30.9% during the fourth quarter. Wells Fargo & Company MN now owns 23,851 shares of the company's stock worth $73,000 after buying an additional 5,625 shares during the period. TD Waterhouse Canada Inc. lifted its stake in shares of Quipt Home Medical by 83.4% during the fourth quarter. TD Waterhouse Canada Inc. now owns 27,435 shares of the company's stock worth $76,000 after buying an additional 12,479 shares during the period. XTX Topco Ltd lifted its stake in shares of Quipt Home Medical by 54.3% during the fourth quarter. XTX Topco Ltd now owns 28,452 shares of the company's stock worth $87,000 after buying an additional 10,015 shares during the period. Finally, Raymond James Financial Inc. acquired a new stake in shares of Quipt Home Medical during the fourth quarter worth $113,000. 42.85% of the stock is currently owned by institutional investors and hedge funds.

Quipt Home Medical Company Profile

Quipt Home Medical Corp., through its subsidiaries, engages in the provision of durable and home medical equipment and supplies in the United States. The company offers nebulizers, oxygen concentrators, and CPAP and BiPAP units; traditional and non-traditional durable medical respiratory equipment and services; non-invasive ventilation equipment, supplies, and services; and engages in the rental of medical equipment.